Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/25/2004US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004US20040235755 Modulating glycolysis enzyme complex/M2-PK and/or by inhibiting transaminases and/or separating the binding of the mitochondrial malate dehydrogenase to p36 protein
11/25/2004US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004US20040235724 Use of specific inhibitors of metalloproteinases (so-called "tissue inhibitor of metalloproteinases 1") for production of a composition for treatment of diseases characterised by increased immunological activity such as multiple sclerosis, Crohn's disease, graft-versus-host disease, autoimmune diseases
11/25/2004US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004US20040235711 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
11/25/2004US20040235135 Preparing viral nucleotide sequences where immune response-inducing antigen sequences are repositioned in the position closest to the 3' end and viral replication limiting factor gene is repositioned away from 3' promoter; for use in generating vaccine to treat and prevent viral infectious diseases
11/25/2004US20040235129 KDEL receptor inhibitors
11/25/2004US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004US20040235113 18 human secreted proteins
11/25/2004US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004US20040235044 Chain-shortened polynucleotide and method for preparation thereof
11/25/2004US20040234969 Using cytochrome p450 gene expression as diagnostic indicator of steroid responsiveness; identifying modulators for treatment and prevention of skin and allergic disorders
11/25/2004US20040234614 Chitin microparticles and their medical uses
11/25/2004US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004US20040234550 Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
11/25/2004US20040234548 treating an allergy in a subject susceptible to an anaphylactic allergic response to an allergen by administering a composition with microorganisms that produce the allergen at an effective and non-toxic dose; compositions with the microorganisms
11/25/2004US20040234545 Aids and leukemia therapy; enhancing immunology response; promote secretion of peptide such as defensin
11/25/2004US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004US20040234527 Peptides for use as translocation factors
11/25/2004US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004US20040234472 Micellar drug delivery systems for hydrophobic drugs
11/25/2004CA2527756A1 Immunostimulating agents
11/25/2004CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004CA2523978A1 Crystal of benzimidazole derivative and process for producing the same
11/24/2004EP1479773A1 Mite galectin
11/24/2004EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004EP1479670A1 Novel fused ring indazole compounds
11/24/2004EP1478762A2 Nucleic acid-associated proteins
11/24/2004EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004EP1478745A2 Kinases and phosphatases
11/24/2004EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/24/2004EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004EP1478659A2 Biologically active peptides
11/24/2004EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004EP1478624A1 Chemical compounds
11/24/2004EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004EP1478394A2 Polypeptide formulation
11/24/2004EP1478393A2 Anti-pathogen treatements
11/24/2004EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function
11/24/2004EP1478378A2 Anti-allergic complex molecules
11/24/2004EP1478376A2 Immunostimulatory agent comprising a biomass of methanotrophic bacterium
11/24/2004EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004EP1478370A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases
11/24/2004EP1478369A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/24/2004EP1478361A2 Arylsulfone derivatives
11/24/2004EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection
11/24/2004EP1478353A1 Sustained release pharmaceutical composition
11/24/2004EP1478340A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
11/24/2004EP1478327A2 Method of reducing and treating uvb-induced immunosuppression
11/24/2004EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004EP1233984B1 PROCESS FOR PRODUCING WASP POISON ALLERGENS WITH REDUCED IgE-REACTIVITY
11/24/2004EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004EP1171587B1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
11/24/2004EP1146883A4 Modulation of immune response by ribavirin
11/24/2004EP1105155B1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
11/24/2004EP1100465B1 Medicinal aerosol formulations
11/24/2004EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
11/24/2004EP0914333B1 Peptide derivatives
11/24/2004EP0830140B1 A pluripotent vaccine against enveloped viruses
11/24/2004EP0717752B1 Therapeutic compounds
11/24/2004CN1549823A Production of high molecular mass lectins
11/24/2004CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004CN1549726A Innate immune system-directed vaccines
11/24/2004CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/24/2004CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004CN1548432A Stabilizing method and medicine composition of catechin monomer
11/24/2004CN1548048A Medicinal composition and tuchahoe extract for raising immunity
11/24/2004CN1548046A Baicalin-zinc medicine
11/24/2004CN1548044A Fumaric acid-ketotifen dispersion tablet and its prepn process
11/24/2004CN1548036A Medicine containing acarnine compound as active component
11/24/2004CN1177053C Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/24/2004CN1177051C Recombinant thymin alpha-1 and its prepn
11/24/2004CN1176941C Caspase inhibitors and the use thereof
11/24/2004CN1176939C Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine
11/24/2004CN1176718C Thymosin alpha-1 microball prepn and its prepn process
11/24/2004CN1176717C Application of buthotoxin Bmk AS in preparing medicines
11/24/2004CN1176699C Lupus treating medicine
11/24/2004CN1176684C Medicine 'Jiwenning' for treating chicken pest and its preparing process
11/24/2004CN1176669C Immune regulator of amino acid calcium from turtle shell and its preparation
11/24/2004CN1176668C Composite biological active capsule and method for preparing the same